Biotechnology Startups That Raised Funding in Usa

Rejuvenate Bio

Location: -

Funding: Closes $6 M

Date: 15 days ago

Rejuvenate Bio is a biotechnology company developing gene therapies to extend healthy lifespan and treat age-related diseases in companion animals, leveraging advanced regenerative biology techniques through partnerships such as with Merck Animal Health.

Moderna

Location: -

Funding: Raised to $34.00

Date: 18 days ago

Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines, developing prophylactic and therapeutic products across infectious diseases, oncology, and rare diseases.

Apogee Therapeutics Inc.

Location: Boston, Massachusetts, United States

Website: apogeetx.com

Funding: Secures Up to $1.3

Date: 21 days ago

Apogee Therapeutics Inc. is a Boston-based clinical-stage biotechnology company focused on developing and commercializing novel immunology therapies, including its lead candidate zumilokibart for the treatment of inflammatory diseases.

POP Biotechnologies, Inc.

Location: Buffalo, NY, USA

Website: pop.bio

Funding: Secures Up to $9.7 M

Date: 22 days ago

POP Biotechnologies, Inc. is a Buffalo-based biotech company developing next-generation vaccines and therapeutics using proprietary porphyrin-phospholipid liposome (SNAP) nanoparticle technology, with its lead vaccine platform advancing toward Phase 1 clinical trials.

Apogee Therapeutics

Location: San Francisco, California

Website: apogeetherapeutics.com

Funding: secures $1.3bn

Date: 29 days ago

Apogee Therapeutics is a clinical-stage biotechnology company developing zumilokibart, a novel anti-IL-13 antibody for moderate-to-severe atopic dermatitis, aiming to improve patient outcomes through targeted immunotherapy.

Vera Therapeutics

Location: -

Funding: Closes Out Entire $18.1 M

Date: 31 days ago

Vera Therapeutics is a clinical-stage biotechnology company developing integrin-targeted small molecule therapies for the treatment of autoimmune and inflammatory diseases.

Nanoviricides

Location: -

Website: nanoviricides.com

Funding: raise $2M

Date: 42 days ago

Nanoviricides is a clinical-stage biopharmaceutical company developing biodegradable polymer-based nanomedicines designed to selectively bind and neutralize viruses, aiming to deliver targeted antiviral therapies.

Kanvas Biosciences

Location: Princeton, New Jersey, USA

Website: kanvasbio.com

Funding: Raises $48M

Date: 50 days ago

Kanvas Biosciences is a Princeton-based biotech company developing a spatial biology platform to analyze the microbiome and advance immuno-oncology therapies, currently launching clinical trials for its lead candidate, KAN-001.

Citius Oncology, Inc.

Location: Cranford, New Jersey

Funding: Secures Up to $36.5 M

Date: 51 days ago

Citius Oncology, Inc. is a clinical-stage biotechnology company focused on developing and commercializing innovative oncology therapies to improve outcomes for cancer patients.

Pacific Hybreed

Location: Big Island, Hawaii

Website: pacifichybreed.com

Funding: Closes $1 M

Date: 52 days ago

Pacific Hybreed is a Big Island-based aquaculture biotechnology company specializing in commercial-scale hatchery production of hybrid shellfish seed to support sustainable shellfish farming and meet growing demand from farmers in Hawaiʻi, the West Coast and beyond.

Annovis Bio, Inc.

Location: Malvern, Pennsylvania

Website: annovisbio.com

Funding: Closes $10 M

Date: 77 days ago

Annovis Bio, Inc. is a Phase 3 clinical-stage biotechnology company developing buntanetap, an investigational oral therapy for neurodegenerative diseases including Alzheimer’s and Parkinson’s, aiming to slow disease progression and improve patient outcomes.

Assembly Biosciences

Location: -

Funding: Raised to $43.00

Date: 78 days ago

Assembly Biosciences is a clinical-stage biotechnology company developing novel small molecule antivirals targeting chronic hepatitis B and D viruses as well as microbiome-based therapeutics for gastrointestinal diseases.

Aktis Oncology

Location: -

Funding: Raised to $33.00

Date: 84 days ago

Aktis Oncology is a clinical-stage biotechnology company developing targeted small-molecule therapies for cancer, focusing on selective kinase inhibitors to treat hematologic and solid tumor malignancies.

Moderna

Location: Cambridge, Massachusetts, USA

Website: moderna.com

Funding: Raised to $48.00

Date: 85 days ago

Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines, leveraging its mRNA platform to rapidly develop novel treatments and preventive vaccines for infectious diseases and other medical conditions.

Denali Therapeutics

Location: South San Francisco, California, USA

Website: denalitherapeutics.com

Funding: Raised to $40.00

Date: 89 days ago

Denali Therapeutics is a clinical-stage biotechnology company developing therapeutics for neurodegenerative diseases by leveraging a proprietary platform to deliver drugs across the blood-brain barrier.

Sarepta Therapeutics

Location: -

Funding: Raised to $13.00

Date: 89 days ago

Sarepta Therapeutics is a biopharmaceutical company focused on developing precision genetic medicines for rare neuromuscular diseases, aiming to transform patient care through innovative therapies.

EpiFrontier Therapeutics, Inc.

Location: Pennington, NJ, USA

Website: epifrontiertx.com

Funding: Secures up to $32M

Date: 94 days ago

EpiFrontier Therapeutics, Inc. is a biotechnology company developing first-in-class epigenetic therapies for beta globin disorders, including EPF-001, a novel G9a inhibitor targeting sickle cell disease and beta thalassemia.

Stoke Therapeutics

Location: -

Funding: Raised to $40.00

Date: 98 days ago

Stoke Therapeutics is a clinical-stage biotechnology company leveraging RNA-based splicing modulation to develop targeted therapies for rare genetic diseases, aiming to restore normal protein production.

Alto Neuroscience

Location: -

Funding: Raised to $22.00

Date: 98 days ago

Alto Neuroscience is a clinical-stage precision neurology company developing biomarker-driven diagnostics and therapeutics to improve treatment selection and outcomes for central nervous system disorders.

Design Therapeutics

Location: -

Funding: Raised to $14.00

Date: 108 days ago

Design Therapeutics is a clinical-stage biotechnology company developing precision gene therapies for rare diseases, leveraging proprietary AAV vector technology to deliver novel genetic medicines.

ACADIA Pharmaceuticals

Location: San Diego, California, USA

Website: acadia.com

Funding: Raised to $35.00

Date: 120 days ago

ACADIA Pharmaceuticals is a biopharmaceutical company that develops and commercializes small molecule therapies for central nervous system disorders, aiming to address unmet medical needs in conditions such as schizophrenia and Parkinson’s disease psychosis.

Vir Biotechnology

Location: -

Funding: Raised to $18.00

Date: 122 days ago

Vir Biotechnology is a clinical-stage immunology company developing innovative therapies, including monoclonal antibodies and immunomodulators, to prevent and treat serious infectious diseases.

Armata Pharmaceuticals

Location: -

Funding: Raised to $15.00

Date: 123 days ago

Armata Pharmaceuticals is a clinical-stage biotechnology company developing bacteriophage-based therapies to treat antibiotic-resistant bacterial infections, offering targeted antimicrobial solutions to address unmet medical needs.

Amylyx Pharmaceuticals

Location: -

Funding: Raised to $19.00

Date: 123 days ago

Amylyx Pharmaceuticals is a biopharmaceutical company developing novel small-molecule therapies for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), with a focus on slowing disease progression and improving patient outcomes.

CytomX Therapeutics

Location: -

Funding: Raised to $10.00

Date: 139 days ago

CytomX Therapeutics is a clinical-stage biotechnology company developing conditionally activated antibody therapies (Probody therapeutics) to selectively target cancer cells while minimizing off-target toxicity, with the goal of delivering safer and more effective cancer treatments.

Tyra Biosciences

Location: -

Funding: Raised to $43.00

Date: 143 days ago

Tyra Biosciences is a clinical-stage biopharmaceutical company developing precision oncology small molecule therapies that target key cancer cell cycle pathways to improve patient outcomes.

Cantai Therapeutics

Location: University City, Philadelphia, PA, USA

Funding: raises $3M

Date: 147 days ago

Cantai Therapeutics is a virtual-model biotechnology startup headquartered in Philadelphia’s University City that develops novel therapeutic solutions, leveraging partnerships and digital infrastructure to streamline drug discovery and development.

Definium Therapeutics

Location: -

Funding: Raised to $36.00

Date: 154 days ago

Definium Therapeutics is a biopharmaceutical company developing epigenetic therapies by targeting histone modifications to regulate gene expression and treat cancer and other diseases.

Vyriad

Location: Rochester, Minnesota

Website: vyriad.com

Funding: raises additional $25M

Date: 163 days ago

Vyriad is a biotechnology company developing genetically engineered viral therapies that selectively target cancer cells to deliver therapeutic genetic payloads, aiming to enhance precision and efficacy in cancer treatment.

Converge Bio

Location: Boston, MA & Tel Aviv, Israel

Website: converge-bio.com

Funding: raises $25M

Date: 164 days ago

Converge Bio is a biotech startup leveraging artificial intelligence to accelerate drug discovery, aiming to shorten R&D timelines and improve the success rate of novel therapeutics.

Avenue Biosciences

Location: Palo Alto, USA and Helsinki, Finland

Funding: raises $5.7 m

Date: 165 days ago

Avenue Biosciences develops a scalable protein manufacturing platform to efficiently produce high-quality proteins for research and therapeutic applications.

Monte Rosa Therapeutics

Location: -

Funding: Raised to $30.00

Date: 166 days ago

Monte Rosa Therapeutics is a biotechnology company leveraging computational and experimental platforms to discover and develop novel allosteric small-molecule modulators targeting G protein-coupled receptors for diseases with high unmet medical needs.

Monte Rosa Therapeutics

Location: -

Funding: Raised to $34.00

Date: 169 days ago

Monte Rosa Therapeutics is a genomics-driven biotechnology company that leverages advanced computational and machine-learning platforms to design targeted immunotherapies for cancer and other diseases, accelerating drug discovery and development.

Sana Biotechnology

Location: -

Funding: Raised to $7.00

Date: 171 days ago

Sana Biotechnology is a biotechnology company developing engineered cells and gene therapies for treating diseases. The company uses gene-editing and cell-engineering techniques to restore or enhance cellular function in patients.

KalVista Pharmaceuticals

Location: -

Funding: Raised to $32.00

Date: 171 days ago

KalVista Pharmaceuticals is a biopharmaceutical company focused on discovering and developing small molecule protease inhibitors for the treatment of protease‐mediated diseases, including hereditary angioedema, with the goal of advancing novel therapeutic candidates through clinical development.

10x Genomics

Location: -

Funding: Raised to $20.00

Date: 183 days ago

10x Genomics develops advanced single-cell and spatial genomics analysis platforms that enable high-resolution cellular and molecular profiling to accelerate research in biology and medicine.

Alphyn Biologics

Location: Cincinnati, Ohio

Funding: lands $25M

Date: 196 days ago

Alphyn Biologics is a Cincinnati-based biotechnology firm developing novel topical biologic therapies for dermatological conditions such as eczema and molluscum contagiosum.

Nuvation Bio

Location: -

Funding: Raised to $18.00

Date: 197 days ago

Nuvation Bio is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for cancer and rare diseases.

Locus Fermentation Solutions

Location: Solon, Ohio, USA

Website: locusfs.com

Funding: Secures $40 M

Date: 198 days ago

Locus Fermentation Solutions is a U.S.-based industrial biotechnology company that uses proprietary fermentation processes to produce performance-enhancing, bio-based intermediates. Its sustainable additive solutions serve oil & gas, mining, agriculture, industrial, and consumer packaged goods markets.

Nurix Therapeutics

Location: San Diego, California

Website: nurix.com

Funding: Raised to $30.00

Date: 198 days ago

Nurix Therapeutics is a clinical-stage biotechnology company discovering and developing small molecule therapeutics that modulate protein homeostasis to treat cancer and immune-inflammatory diseases.

Senti Biosciences

Location: -

Funding: Raised to $13.00

Date: 199 days ago

Senti Biosciences is a clinical-stage synthetic biology company that engineers programmable gene circuits to develop targeted cell therapies for treating complex diseases.

IGC Pharma

Location: -

Funding: Raised to $4.75

Date: 199 days ago

IGC Pharma is a clinical-stage biopharmaceutical company developing immune cell therapies to treat autoimmune diseases and prevent transplant rejection through regulatory cell modulation.

Arcus Biosciences

Location: -

Funding: Raised to $26.00

Date: 207 days ago

Arcus Biosciences is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies that target immune checkpoints to enhance anti-tumor responses. Its pipeline includes small molecules and biologics aimed at improving the efficacy and safety of cancer treatments.

Moderna

Location: Cambridge, Massachusetts, USA

Website: modernatx.com

Funding: Secures $1.5

Date: 213 days ago

Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines, leveraging its proprietary platform to develop and manufacture treatments for infectious diseases, immuno-oncology, rare diseases, and cardiovascular conditions.

Olema Pharmaceuticals

Location: -

Funding: Raised to $26.00

Date: 217 days ago

Olema Pharmaceuticals is a clinical-stage biotechnology company focused on developing novel therapies for inflammatory and dermatological diseases, including psoriasis and atopic dermatitis.

Scholar Rock

Location: -

Funding: Raised to $45.00

Date: 221 days ago

Scholar Rock is a clinical-stage biopharmaceutical company developing targeted protein therapeutics that modulate the TGF-β superfamily to treat serious muscular and fibrotic diseases.

Cidara Therapeutics

Location: -

Funding: Secures $9.2 Billion

Date: 223 days ago

Cidara Therapeutics is a clinical-stage biotechnology company developing novel long-acting anti-infective and immunomodulatory therapies to treat and prevent serious infectious diseases.

Regeneron Pharmaceuticals

Location: Saratoga Springs, New York, USA

Website: regeneron.com

Funding: lands $2 billion

Date: 224 days ago

Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, and manufactures innovative biologic therapies for serious diseases. Leveraging proprietary technology platforms, it accelerates drug discovery and scales production to bring transformative treatments to market.

Terns Pharmaceuticals

Location: -

Funding: Raised to $33.00

Date: 225 days ago

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and immune-mediated diseases, including treatments for non-alcoholic steatohepatitis (NASH).

Nanoviricides

Location: -

Funding: closes $6M

Date: 225 days ago

Nanoviricides is a nanomedicine biotechnology company developing targeted antiviral therapies using proprietary nanomicelle technology to treat a broad range of viral infections.

Modulight Biotherapeutics

Location: United States

Funding: secures $12m

Date: 226 days ago

Modulight Biotherapeutics is a U.S.-based biotechnology startup developing optogenetic therapies that precisely target neurons to treat neurological disorders.

Adaptive Biotechnologies

Location: -

Funding: Raised to $16.00

Date: 227 days ago

Adaptive Biotechnologies is a biotechnology company leveraging its proprietary immune medicine platform to decode the adaptive immune system and develop diagnostic tools and therapies across a range of diseases.

Nanoviricides

Location: Shelton, Connecticut, USA

Website: nanoviricides.com

Funding: raises $6M

Date: 227 days ago

Nanoviricides develops nanotechnology-based antiviral therapeutics that mimic the body’s immune mechanisms to specifically target and neutralize viruses, aiming to provide effective treatments for a broad range of viral infections.

Relay Therapeutics

Location: -

Funding: Raised to $6.00

Date: 228 days ago

Relay Therapeutics is a biotechnology company that leverages computational modeling and protein motion analysis to discover and develop novel small-molecule therapies targeting various diseases.

Maze Therapeutics

Location: -

Funding: Raised to $36.00

Date: 228 days ago

Maze Therapeutics is a clinical-stage biotechnology company that leverages human genetics and functional genomics to discover and develop novel therapies for cardiometabolic and other diseases.

Metsera

Location: New York, USA

Funding: Secures $10 Billion

Date: 229 days ago

Metsera is a New York–based biotechnology company developing novel obesity drugs, offering innovative therapies for the rapidly expanding weight-loss market.

NewAmsterdam Pharma

Location: -

Funding: Raised to $44.00

Date: 230 days ago

NewAmsterdam Pharma is a clinical-stage biopharmaceutical company developing therapies that enhance nitric oxide availability to treat metabolic and cardiovascular diseases.

Exelixis

Location: -

Funding: Raised to $40.00

Date: 230 days ago

Exelixis is an oncology-focused biopharmaceutical company that discovers, develops, and commercializes small molecule therapies to treat cancer.

Dianthus Therapeutics

Location: -

Funding: Raised to $46.00

Date: 230 days ago

Dianthus Therapeutics is a clinical-stage biotechnology company developing targeted protein degradation therapies to treat cancer and immune diseases, leveraging a proprietary platform to discover and optimize novel molecular degraders.

Adicet Bio

Location: -

Funding: Raised to $9.00

Date: 231 days ago

Adicet Bio is a clinical-stage biotechnology company developing off-the-shelf gamma delta T cell therapies to treat cancer and other diseases. The company's proprietary allogeneic platform enables scalable, cost-effective cell therapy solutions with enhanced safety and efficacy.

Adaptive Biotechnologies

Location: -

Funding: Raised to $20.00

Date: 232 days ago

Adaptive Biotechnologies uses proprietary immune repertoire sequencing to develop diagnostics and therapeutics, enabling precise disease detection and monitoring by mapping the adaptive immune response.

Amicus Therapeutics

Location: -

Funding: Raised to $11.00

Date: 233 days ago

Amicus Therapeutics is a biopharmaceutical company specializing in developing treatments for rare genetic diseases, using enzyme replacement and small molecule therapies to address underlying disease mechanisms.

Rigel Pharmaceuticals

Location: -

Funding: Raised to $38.00

Date: 233 days ago

Rigel Pharmaceuticals is a biopharmaceutical company developing novel small molecule therapies for inflammatory diseases, immune disorders, and cancer.

Rigel Pharmaceuticals

Location: -

Funding: Raised to $38.00

Date: 233 days ago

Rigel Pharmaceuticals is a biotechnology company specializing in the discovery, development, and commercialization of small molecule therapies for immunologic, hematologic, and oncologic diseases.

SylamoreBio

Location: Jonesboro, Arkansas

Funding: secure $3M

Date: 239 days ago

SylamoreBio is a biotechnology company based at Arkansas State University in Jonesboro, Arkansas, focused on developing innovative biotherapeutics and advancing life-saving research through federally funded NIH SBIR programs.

Kyverna Therapeutics

Location: -

Funding: Raised to $20.00

Date: 239 days ago

Kyverna Therapeutics is a clinical-stage biotechnology company developing CRISPR-based gene editing and allogeneic cell therapies targeting genetic blood disorders and immuno-oncology, aiming to provide off-the-shelf engineered T-cell treatments for diseases such as sickle cell disease and cancer.

Pinetree Therapeutics

Location: Cambridge, MA

Website: pinetreetx.com

Funding: Raises $47 M

Date: 240 days ago

Pinetree Therapeutics is a preclinical-stage biotechnology company developing targeted protein degraders for drug-resistant cancers, leveraging its proprietary AbReptor™ platform to advance lead oncology programs into clinical development.

Kaleira Therapeutics

Location: Waltham, Massachusetts

Website: kailera.com

Funding: raised $1

Date: 248 days ago

Kaleira Therapeutics is a growth-stage biotechnology company developing novel therapeutic candidates to address serious diseases and unmet medical needs through advanced research and development.

Bexorg, Inc.

Location: New Haven, Connecticut, USA

Website: bexorg.com

Funding: Raises $42.5M

Date: 254 days ago

Bexorg, Inc. operates an AI-driven, whole human brain platform to accelerate and improve predictive discovery and development of central nervous system drugs.

Emergent BioSolutions Inc.

Location: Gaithersburg, Maryland, USA

Website: emergentbiosolutions.com

Funding: Secures $29 M

Date: 280 days ago

Emergent BioSolutions is a biotechnology company that develops, manufactures, and supplies medical countermeasures—including vaccines, therapeutics, and devices—to protect against infectious diseases, chemical, and radiological threats for government and public health partners.

Mineralys Therapeutics

Location: -

Funding: Raised to $43.00

Date: 299 days ago

Mineralys Therapeutics is a clinical-stage biotechnology company developing novel small-molecule ion channel modulators to treat cardiometabolic and neuropsychiatric disorders, aiming to deliver precision medicines with improved efficacy and safety.

Debut

Location: San Diego, California, U.S.

Funding: Secures $20M

Date: 304 days ago

Debut is a San Diego-based biotech startup that leverages an AI-driven ingredient discovery platform to develop and formulate novel skincare solutions aimed at advancing skin longevity, with growing operations in Asian markets.

Tahoe Therapeutics

Location: Palo Alto, California, U.S.

Funding: Raises $30M

Date: 319 days ago

Tahoe Therapeutics is a Palo Alto-based biotech company that uses its AI-driven Mosaic platform and Tahoe-100M dataset to simulate human cells for cancer drug discovery, aiming to accelerate the development of precision medicine therapies.

Vivodyne

Location: Philadelphia, PA

Website: vivodyne.com

Funding: raised $40 m

Date: 389 days ago

Vivodyne is a biotechnology company that develops human tissue-based platforms to replace animal testing in drug development, aiming to accelerate drug discovery and reduce related costs.

Vivodyne

Location: South San Francisco, CA

Website: vivodyne.com

Funding: Secures $40M

Date: 392 days ago

Vivodyne develops an AI and robotics-powered platform for human tissue testing, enabling advanced and scalable solutions for biomedical research and drug development.

Mito Robotics

Location: Pittsburgh, PA

Funding: raises $1M

Date: 400 days ago

Mito Robotics develops automated solutions to improve and scale cell growth processes in laboratories, addressing challenges in biomanufacturing for advanced therapies such as exosome treatment and organ transplants.

Imprint

Location: New York City, NY

Website: imprint.bio

Funding: raises $15 m

Date: 402 days ago

Imprint is a biotechnology startup focused on decoding immune memory to advance personalized medicine and immunotherapy. The company originated from Cornell Tech’s Runway program and leverages cutting-edge research to deliver innovative healthcare solutions.

ACADIA Pharmaceuticals

Location: -

Funding: Raised to $31.00

Date: 403 days ago

ACADIA Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of therapies for central nervous system disorders, including Parkinson’s disease psychosis.

Armata Pharmaceuticals

Location: -

Website: armatapharma.com

Funding: Raised to $9.00

Date: 403 days ago

Armata Pharmaceuticals is a clinical-stage biotechnology company developing bacteriophage-based and immunotherapeutic solutions to treat serious bacterial infections and combat antibiotic resistance.

Enliven Therapeutics

Location: -

Funding: Raised to $40.00

Date: 405 days ago

Enliven Therapeutics is a clinical-stage biotechnology company developing novel small molecule therapies that modulate epigenetic and immune pathways to treat cancer.

Therini Bio, Inc.

Location: Sacramento, Calif.

Website: therinibio.com

Funding: Raises Additional $39M

Date: 408 days ago

Therini Bio, Inc. is a clinical-stage biotechnology company developing fibrin-targeting immunotherapies aimed at treating neurodegenerative diseases driven by vascular dysfunction, including Alzheimer's disease.

Agenus

Location: -

Funding: Raised to $4.00

Date: 409 days ago

Agenus is a biotechnology company focused on developing immuno-oncology therapies and vaccine adjuvants designed to harness and enhance the immune system’s response against cancer and infectious diseases.

Trailhead Biosystems

Location: Beachwood, OH

Website: trailbio.com

Funding: Raises $20M

Date: 412 days ago

Trailhead Biosystems specializes in human cell innovation, utilizing an informatics-driven approach to develop iPSC-derived cells for applications in regenerative medicine, preclinical drug discovery, and disease modeling.

ImmuneWalk Therapeutics

Location: NYC, USA

Website: immunewalk.com

Funding: Raises $7M

Date: 414 days ago

ImmuneWalk Therapeutics is a clinical-stage biotechnology company developing therapies focused on modulating immune and inflammatory diseases through monocyte inhibition.

Stately Bio

Location: Palo Alto, CA

Website: statelybio.com

Funding: Raises $12M

Date: 420 days ago

Stately Bio develops regenerative medicine therapies using a patented machine learning-powered live-cell imaging platform, notably producing liver cells with significantly enhanced functionality compared to existing technologies.

Grove Biopharma

Location: Chicago, Illinois

Funding: secures $30 m

Date: 427 days ago

Grove Biopharma is a biotechnology startup founded by Northwestern University researchers, focused on developing new classes of drugs aimed at treating cancer and other diseases.

Araceli Biosciences

Location: Portland, OR

Website: aracelibio.com

Funding: Closes $11.2M

Date: 428 days ago

Araceli Biosciences specializes in high-content imaging and AI-powered analysis, enabling advancements in personalized medicine through innovative hardware and software solutions for real-time biomedical analysis.

Grove Biopharma

Location: Chicago, IL

Website: grovebiopharma.com

Funding: Raises $30M

Date: 428 days ago

Grove Biopharma is a biotechnology company focused on advancing its proprietary platform to develop oncology treatments, aiming to move its lead programs toward clinical trials.

Atossa Therapeutics

Location: -

Funding: Raised to $7.25

Date: 428 days ago

Atossa Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for breast cancer and other breast conditions.